Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4334-4342

  Engbrecht, Brett W ^a   Menon, Chandrakala ^a   Kachur, Alexander V ^a   Hahn, Stephen M ^a   Fraker, Douglas L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SARCOMA; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME; TUMOR CELL; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOOD VESSELS; DIHEMATOPORPHYRIN ETHER; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; REGIONAL BLOOD FLOW; SARCOMA, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033199866     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst., 85: 443-456, 1993.
2. 14C]nematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res., 39: 146-151, 1979.
3. Woodburn, K. W., Fan, Q., Miles, D. R., Kessel, D., Luo, Y., and Young, S. W. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem. Photobiol., 65: 410-415, 1997.
4. Dougherty, T. J., Gomer, D. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
5. Clan, W. S., Brasseur, N., La Madeleine, C., and van Lier, J. E. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin. Anticancer Res., 16: 1887-1892, 1996.
6. Henderson, B. W., Waldow, S. M., Mang, T. S., Potter, W. R., Malone, P. B., and Dougherty, T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45: 572-576, 1985.
7. Kessel, D., Woodbum, K., Henderson, B. W., and Chang, C. K. Sites of photodamage in vivo and in vitro by a cationic porphyrin. Photochem. Photobiol., 62: 875-881, 1995.
8. McMahon, K. S., Wieman, T. J., Moore, P. H., and Fingar, V. H. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res., 54: 5374-5379, 1994.
9. van Geel, I. P., Oppelaar, H., Oussoren, Y. G., and Stewart, F. A. Changes in perfusion of mouse tumours after photodynamic therapy. Int. J. Cancer, 56: 224-228, 1994.
10. Fingar, V. H., Wieman, T. J., Karavolos, P. S., Doak, K. W., Quellet, R., and van Lier, J. E. The effects of photodynamic therapy using differently substituted zinc phtha-locyanines on vessel constriction, vessel leakage, and tumor response. Photochem. Photobiol., 58: 251-258, 1993.
11. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
12. Reed, M. W. R., Wieman, T., Schuschke, D. A., and Teng, M. T., and Miller, F. N. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res., 119: 542-552, 1989.
13. Fingar, V. H. Vascular effects of photodynamic therapy. J. Clin. Laser Med. Surg., 14: 323-328, 1996.
14. Wieman., T. J., Mang, T. S., Fingar, V. H., Hill, T. G., Reed, M. W., Corey, T. S., Nguyen, V. Q., and Render, E. R. Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery, 104: 512-517, 1988.
15. Fingar, V. H., Wieman, T. J., Wiehle, S. A., and Cerrito, P. B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res., 52: 4914-4921, 1992.
16. Orenstein, A., Nelson, J. S., Liaw, L. H., Kaplan, R., Kumel, S., and Berns, S. W. Photochemotherapy of hypervascular dermal lesions: a possible alternative to photochemical therapy? Lasers Surg. Med., 10: 334-343, 1990.
17. Zaidi, S. I., Oleinick, N. L., Zaim, M. T., and Muktar, H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol., 58: 771-776, 1993.
18. Webber, J., Luo, Y., Crilly, R., Fromm, D., and Kessel, D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J. Photochem. Photobiol., 35: 209-211, 1996.
19. Oleinick, N. L., and Evans, H. H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res., 150: S146-S156, 1998.
20. Peng, Q., Moan, J., and Nesland, J. M. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol., 20: 109-129, 1996.
21. Tochner, Z., Mitchell, J. B., Smith, P., Harrington, F., Glatstein, E., Russo, D., and Russo, A. Photodynamic therapy of ascites tumours within the peritoneal cavity. Br. J. Cancer, 53: 733-736, 1986.
22. Cincotta, L., Foley, J. W., and Cincotta, A. H. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells. Cancer Res., 53: 2571-2580, 1993.
23. Cincotta, L., Szeto, D., Lamprox, E., and Hasan, T., and Cincotta, A. H. Benzophenothiazine and benozoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem. Photobiol., 63: 229-237, 1996.
24. Nambisan, R. N., Karakousis, C. P., Holyoke, E. D., and Dougherty, T. J. Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (Phila.), 61: 1248-1252, 1988.
25. Sindelar, W. F., Sullivan, F. J., Abraham, E., Delaney, T. F., Smith, P. D., Friauf, G. F., Smith, B., and Ohnieff, P. O. Intraperitoneal photodynamic therapy shows efficacy in Phase I trial. Proc. Am. Soc. Clin. Oncol., 14: 477, 1995.
26. Bellnier, D. A., Greco, W. R., Parsons, J. C., Oseroff, A. R., Kuebler, A., and Dougherty, T. J. An assay for the quantitation of Photofrin in tissues and fluids. Photochem. Photobiol., 66: 237-244, 1997.
27. Biel, M. A. Photodynamic therapy and the treatment of head and neck cancers. J. Clin. Laser Med. Surg., 14: 239-244, 1996.
28. Grant, W. E., Speight, P. M., Hopper, C., and Bown, S. G. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int. J. Cancer, 71: 937-942, 1997.
29. Cortese, D. A., Edell, E. S., and Kinsey, J. H. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin. Proc., 72: 595-602, 1997.
30. McCaughan, J. S., and Williams, T. E. Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J. Thorac. Cardiovasc. Surg., 114: 940-947, 1997.
31. Mostal, T. L., Dougherty, T. S., Urschel, J. D., Antowiok, J. G., Regal, A. M., Driscoll, D. L., and Tahiti, H. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann. Thorac. Surg., 66: 1128-1133, 1998.
32. Pass, H. I., Delaney, T. F., Tochner, Z., Smith, P. E. Temeck, B. K. Pogrebniak, H. W., Kranda, K. C., Russo, A., Friauf, W. S., Cole, J. W., Mitchell, J. B., and Thomas, G. Intrapleural photodynamic therapy: results of a Phase I trial. Ann. Surg. Oncol., 1: 28-37, 1994.
33. Lightdale, C. J., Heier, S. K., Marcon, N. E., McCaughan, J. S., Gerdes, H., Overholt, B. F., Sivak, M. V., Stiegmann, G. V., and Nava, H. R. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest. Endosc., 42: 507-512, 1995.
34. Sitnik, T. M., Hampton, J. A., and Henderson, B. W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer, 77: 1386-1394, 1998.
35. Sitnik, T. M., and Henderson, B. W. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol., 67: 462-466, 1998.
36. Robinson, D. J., de Bruijn, H. S., van der Veen, N., and Stringer, M. R., Brown, S. B., and Star, W. M. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol. 67: 140-149, 1998.
37. Foster, T. H., Murant, R. S., Bryant, R. G., Knox, R. S., Gibson, S. L., and Hilf, R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res., 126: 296-303, 1991.
38. Lin, C. W. Selective localization of photosensitizers in tumors: a review of the phenomenon and possible mechanisms. In. D. Kessel (ed.), Photodynamic Therapy of Neoplastic Disease, pp. 79-101. Boca Raton, FL: CRC Press, 1990.
39. Chan, W. S., Brasseur, N., la Madeleine, C., and van Lier, J. E. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulphonated aluminum phthalocyanine or Photofrin: tumor cell survival and blood flow. Anticancer Res., 16: 1887-1892, 1996.
40. Riva, C., Chauvin, C., Pison, C., and Leverue, X. Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res., 18: 4729-4736, 1998.
41. Araya, R., Uehara, T., and Nomura, Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett., 439: 168-172, 1998.
42. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brussellmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Callen, D., and Keshet, E. Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation and tumor angiogenesis. Nature (Lond.), 394: 485-490, 1998.